Wednesday, October 21

Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India – News18

Email address and unique API key are both required. At least one is missing.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.